Abstract:Despite the current promise of immunotherapy, many cancer patients still suffer from challenges such as poor immune response rates, resulting in unsatisfactory clinical efficacy of existing therapies. There is an urgent need to combine emerging biomedical discoveries and innovations in traditional therapies. Modulation of the cGAS-STING signalling pathway represents an important innate immunotherapy pathway that serves as a crucial DNA sensing mechanism in innate immunity and viral defense. It has attracted increasing attention as an emerging target for cancer therapy. The recent advancements in nanotechnology have led to the significant utilization of nanomaterials in cancer immunotherapy, owing to their exceptional physicochemical properties such as large specific surface area and efficient permeability. Given the rapid development of cancer immunotherapy driven by the cGAS-STING activation, this study reviews the latest research progress in employing nanomaterials to modulate this signaling pathway. Based on the introduction of the main activation mechanisms of cGAS-STING pathway, this review focuses on nanomaterials that mediate the agonists involved and effectively activate this signaling pathway. In addition, combination nanotherapeutics based on the activation of the cGAS-STING signaling pathway are also discussed, including emerging strategies combining nanoformulated agonists with chemotherapy, radiotherapy as well as other immunomodulation in tumor targeting therapy. Statement of Significance Given the rapid development of cancer immunotherapy driven by the cGAS / STING activation, this study reviews the latest research advances in the use of nanomaterials to modulate this signaling pathway. Based on the introduction of key cGAS-STING components and their activation mechanisms, this review focuses on nanomaterials that can mediate the corresponding agonists and effectively activate this signaling pathway. In addition, combination nanotherapies based on the activation of the cGAS-STING signaling pathway are also discussed, including emerging strategies combining nanoformulated agonists with chemotherapy, radiotherapy as well as immunomodulation in cancer therapy,.

cGAS-STING pathway in cancer biotherapy

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

Cgas-Sting, an Important Pathway in Cancer Immunotherapy.

The cGAS/STING Pathway: A Novel Target for Cancer Therapy

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy

cGAS-STING signaling in cancer immunity and immunotherapy

Strategies involving STING pathway activation for cancer immunotherapy: mechanism and agonists

The multiple faces of cGAS-STING in antitumor immunity: prospects and challenges

Therapeutic targeting of cGAS–STING pathway in lung cancer

Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy

Cancer Immunotherapy Strategies That Target the Cgas-Sting Pathway.

Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy

STING Activation in Cancer Immunotherapy

Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies

Nanoparticle‐Mediated STING Activation for Cancer Immunotherapy

Biomaterial-enabled Therapeutic Modulation of Cgas-Sting Signaling for Enhancing Antitumor Immunity.

Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy

Agonists and Inhibitors of the Cgas-Sting Pathway

GAS-STING: a classical DNA recognition pathways to tumor therapy

cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors